Details for New Drug Application (NDA): 083342
✉ Email this page to a colleague
NDA 083342 describes MAXIDEX, which is a drug marketed by Alcon and Harrow Eye and is included in two NDAs. It is available from one supplier. Additional details are available on the MAXIDEX profile page.
The generic ingredient in MAXIDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
The generic ingredient in MAXIDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 083342
| Tradename: | MAXIDEX |
| Applicant: | Alcon |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | EQ 0.05% PHOSPHATE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
